Psilocybin Shows Promise for Cocaine Use Disorder: JAMA Medha Baranwal10 Jun 2026 8:15 PM ISTUSA: A randomized clinical trial has found that psilocybin appeared to be safe and effective in treating cocaine use disorder, including among...
Intravenous Ketamine infusions effective for reducing Acute Suicidal and Depressive Symptoms: JAMA Dr Riya Dave19 May 2026 8:30 PM ISTResearchers have found in a systematic review and meta-analysis that single and repeated intravenous infusions of Ketamine are effective in rapidly...
Adjunctive Atypical Antipsychotics May Differ in Efficacy and Acceptability in Resistant Depression: JAMA Medha Baranwal15 May 2026 9:00 PM ISTCanada: A systematic review and network meta-analysis have found that adjunctive atypical antipsychotics differ in both efficacy and acceptability...
Oral Semaglutide Shows Promise for Motivation in Depression, Finds Research Medha Baranwal13 May 2026 3:00 PM ISTCanada: Researchers have found in secondary analysis of a randomized trial that treatment with Semaglutide (Rybelsus) was associated with significant...
Dialectical Behavior Therapy and Schema Therapy Show Comparable Effectiveness in Borderline Personality Disorder: JAMA Aashi verma7 May 2026 8:00 PM ISTA multicenter randomized controlled trial has found no significant difference in effectiveness between Dialectical Behavior Therapy and Schema Therapy...
Mirtazapine Reduces Methamphetamine Use in methamphetamine use disorder: JAMA Jacinthlyn Sylvia29 April 2026 8:00 PM ISTA phase III placebo-controlled trial published in the Journal of the American Medical Association demonstrated that mirtazapine use in routine...
N-Methyl Amisulpride Shows Short-Term Efficacy in Acute Schizophrenia in Phase 2 Trial Medha Baranwal27 April 2026 8:15 PM ISTUSA: An investigational benzamide antipsychotic, N-methyl amisulpride, demonstrated significant symptom improvement in hospitalized adults with...
Psilocybin Therapy Shows Limited Benefit in Treatment-Resistant Depression: JAMA Medha Baranwal3 April 2026 8:30 PM ISTGermany: A new phase IIb EPISODE trial revealed that psilocybin combined with psychotherapy failed to meet the primary endpoint in treatment-resistant...
GH001 Shows Promise as Rapid-Acting Therapy for Treatment-Resistant Depression: JAMA Aashi verma27 March 2026 8:30 PM ISTAn individualized dosing regimen of GH001, a synthetic inhaled form of mebufotenin, significantly improved depressive symptoms compared to placebo and...
Sleep and mental health disorders may mediate increased ACS risk: JAMA Jacinthlyn Sylvia26 March 2026 8:15 PM ISTA new study published in the Journal of the American Medical Association found growing link between mental health and heart disease, which revealed...
Investigational TSND-201 Shows Early and Significant Efficacy in Severe PTSD in Phase II Trial Medha Baranwal23 Feb 2026 8:45 PM ISTUSA: The investigational neuroplastogen TSND-201 demonstrated significant efficacy in patients with severe post-traumatic stress disorder (PTSD) in a...
Wearable trackers can detect depression relapse weeks before it returns, study finds Dr. Kamal Kant Kohli15 Feb 2026 8:00 PM ISTCould a smart watch act as an early-warning system for depression relapse? New research from McMaster University suggests that disruptions in a...
